KCNMB4
Calcium-activated potassium channel subunit beta-4
Also known as: KCMB4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86W47
- Gene
- KCNMB4
- Ensembl
- ENSG00000135643
- Chromosome
- 12
- Canonical length
- 210 aa
- Protein class
- FDA approved drug targets, Predicted membrane proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
MaxiK channels are large conductance, voltage and calcium-sensitive potassium channels which are fundamental to the control of smooth muscle tone and neuronal excitability. MaxiK channels can be formed by 2 subunits: the pore-forming alpha subunit and the modulatory beta subunit. The protein encoded by this gene is an auxiliary beta subunit which slows activation kinetics, leads to steeper calcium sensitivity, and shifts the voltage range of current activation to more negative potentials than does the beta 1 subunit. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
210 residues, UniProt reviewed canonical sequence.
>Q86W47|KCNMB4
1 MAKLRVAYEY TEAEDKSIRL GLFLIISGVV SLFIFGFCWL SPALQDLQAT EANCTVLSVQ
61 QIGEVFECTF TCGADCRGTS QYPCVQVYVN NSESNSRALL HSDEHQLLTN PKCSYIPPCK
121 RENQKNLESV MNWQQYWKDE IGSQPFTCYF NQHQRPDDVL LHRTHDEIVL LHCFLWPLVT
181 FVVGVLIVVL TICAKSLAVK AEAMKKRKFSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KCNMB4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 2
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 38 nTPM
Expression across tissuesHPA
Tissue
- hippocampal formation: 38 nTPM
- amygdala: 29 nTPM
- cerebral cortex: 28 nTPM
- spinal cord: 27 nTPM
- midbrain: 25 nTPM
- basal ganglia: 24 nTPM
Single-cell type
- schwann cells: 642 nCPM
- oligodendrocytes: 250 nCPM
- brain excitatory neurons: 118 nCPM
- retinal bipolar cells: 101 nCPM
- renal collecting duct principal cells: 92 nCPM
- ependymal cells: 90 nCPM
Immune cell
- naive CD8 T-cell: 0.6 nTPM
- naive CD4 T-cell: 0.4 nTPM
- naive B-cell: 0.3 nTPM
- basophil: 0.1 nTPM
- memory B-cell: 0.1 nTPM
- memory CD4 T-cell: 0.1 nTPM
Brain region
- white matter: 77 nTPM
- cerebral cortex: 57 nTPM
- basal ganglia: 47 nTPM
- medulla oblongata: 46 nTPM
- thalamus: 45 nTPM
- amygdala: 39 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.34
- gnomAD pLI
- 0.94
- gnomAD missense Z
- 2.06
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- action potential
- chemical synaptic transmission
- detection of calcium ion
- neuronal action potential
- potassium ion transport
- regulation of neurotransmitter secretion
- regulation of vasoconstriction
Molecular functions
- calcium-activated potassium channel activity
- potassium channel regulator activity
- voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of KCNMB4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KCNMB4 as an antibody target. Whether an autoantibody or antibody against KCNMB4 could matter depends on whether native KCNMB4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KCNMB4 is annotated at the cell surface, where native KCNMB4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label KCNMB4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...